Cargando…
Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study
The IMMray PanCan-d test combines an 8-plex biomarker signature with CA19-9 in a proprietary algorithm to detect pancreatic ductal adenocarcinoma (PDAC) in serum samples. This study aimed to validate the clinical performance of the IMMray PanCan-d test and to better understand test performance in Le...
Autores principales: | Brand, Randall E., Persson, Jan, Bratlie, Svein Olav, Chung, Daniel C., Katona, Bryson W., Carrato, Alfredo, Castillo, Marién, Earl, Julie, Kokkola, Arto, Lucas, Aimee L., Moser, A. James, DeCicco, Corinne, Mellby, Linda Dexlin, King, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963856/ https://www.ncbi.nlm.nih.gov/pubmed/35166713 http://dx.doi.org/10.14309/ctg.0000000000000468 |
Ejemplares similares
-
Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays
por: Gerdtsson, Anna S., et al.
Publicado: (2016) -
Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma: A National Registry Study
por: Johansen, Karin, et al.
Publicado: (2021) -
Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics
por: Delfani, Payam, et al.
Publicado: (2016) -
PACADI: translation and adaptation of a Swedish-language version of the pancreatic cancer disease impact score
por: Andersson, Thomas, et al.
Publicado: (2022) -
Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
por: Ciernikova, Sona, et al.
Publicado: (2020)